Oscar Health, Inc. (NYSE:OSCR) Shares Acquired by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. increased its position in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 19.3% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,125,355 shares of the company's stock after acquiring an additional 182,206 shares during the quarter. Charles Schwab Investment Management Inc. owned approximately 0.51% of Oscar Health worth $6,268,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently modified their holdings of OSCR. Covestor Ltd increased its stake in Oscar Health by 310.0% during the second quarter. Covestor Ltd now owns 3,329 shares of the company's stock worth $27,000 after acquiring an additional 2,517 shares during the last quarter. Dark Forest Capital Management LP increased its position in shares of Oscar Health by 5,243.2% during the 1st quarter. Dark Forest Capital Management LP now owns 7,801 shares of the company's stock worth $51,000 after purchasing an additional 7,655 shares during the last quarter. Metropolitan Life Insurance Co NY raised its holdings in Oscar Health by 63.9% in the 2nd quarter. Metropolitan Life Insurance Co NY now owns 8,520 shares of the company's stock valued at $69,000 after buying an additional 3,323 shares during the period. Advisor Group Holdings Inc. lifted its position in Oscar Health by 157.5% in the first quarter. Advisor Group Holdings Inc. now owns 10,106 shares of the company's stock valued at $101,000 after buying an additional 6,182 shares during the last quarter. Finally, Royal Bank of Canada boosted its stake in Oscar Health by 959.5% during the third quarter. Royal Bank of Canada now owns 10,129 shares of the company's stock worth $50,000 after buying an additional 9,173 shares during the period. Hedge funds and other institutional investors own 66.70% of the company's stock.

Insider Transactions at Oscar Health

In related news, CFO Richard Scott Blackley sold 30,029 shares of Oscar Health stock in a transaction that occurred on Wednesday, December 6th. The shares were sold at an average price of $8.16, for a total value of $245,036.64. Following the completion of the transaction, the chief financial officer now owns 548,613 shares in the company, valued at $4,476,682.08. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Oscar Health news, CFO Richard Scott Blackley sold 30,029 shares of the firm's stock in a transaction on Wednesday, December 6th. The stock was sold at an average price of $8.16, for a total value of $245,036.64. Following the sale, the chief financial officer now directly owns 548,613 shares in the company, valued at $4,476,682.08. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Alessandrea C. Quane sold 16,793 shares of Oscar Health stock in a transaction dated Wednesday, December 6th. The stock was sold at an average price of $8.16, for a total value of $137,030.88. Following the sale, the executive vice president now directly owns 301,223 shares of the company's stock, valued at $2,457,979.68. The disclosure for this sale can be found here. Corporate insiders own 25.54% of the company's stock.

Oscar Health Price Performance

Oscar Health stock opened at $16.58 on Monday. The company's 50 day moving average is $13.00 and its two-hundred day moving average is $8.85. The firm has a market cap of $3.81 billion, a PE ratio of -13.82 and a beta of 1.82. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.37. Oscar Health, Inc. has a 52-week low of $3.22 and a 52-week high of $18.55.

Oscar Health (NYSE:OSCR - Get Free Report) last released its earnings results on Wednesday, February 7th. The company reported ($0.66) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.74) by $0.08. The firm had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.43 billion. Oscar Health had a negative return on equity of 29.99% and a negative net margin of 4.62%. Oscar Health's revenue was up 43.9% compared to the same quarter last year. During the same period last year, the business posted ($1.05) earnings per share. On average, research analysts expect that Oscar Health, Inc. will post -0.12 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on OSCR shares. TheStreet upgraded shares of Oscar Health from a "d" rating to a "c-" rating in a report on Wednesday, February 21st. The Goldman Sachs Group upped their price target on Oscar Health from $8.00 to $16.00 and gave the stock a "neutral" rating in a research note on Friday, February 9th. Finally, Wells Fargo & Company lifted their price objective on Oscar Health from $12.00 to $20.00 and gave the company an "overweight" rating in a research note on Thursday, February 15th. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $12.20.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.